Navigation Links
Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
Date:6/24/2009

Seventy-Seven Percent of Surveyed Physicians Will Increase Their Use of Carbapenems In the Next Five Years, According to a New Report from AMR and Decision Resources

MALVERN, Pa. and WALTHAM, Mass., June 24 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that availability in both intravenous and oral formulation is a leading drug attribute that surveyed physicians prefer for the treatment of complicated urinary tract infections (UTIs) in the hospital setting. Antibiotics available in interchangeable oral and parenteral formulations can facilitate step-down therapy and discharge from the hospital to the outpatient setting.

"Physicians prescribe a wide variety of antibiotics for UTIs, mainly from the quinolone and cephalosporin classes," stated Lisa Arias, analyst at Decision Resources. "These broad-spectrum agents are popular first-line agents in UTIs, and oral quinolones, in particular, have become a popular choice for first-line, step-down and discharge therapy."

The new report entitled Hospital Anti-Infectives Insight Series: Urinary Tract Infections also finds that extended-spectrum beta-lactamase-producing and quinolone-resistant gram-negative pathogens are among the most concerning pathogens, and that 77 percent of surveyed physicians expect to increase their prescribing of carbapenems for complicated UTIs in the next five years. These potent, broad-spectrum antibiotics are especially useful for treating gram-negative infections involving resistant organisms.

About Hospital Anti-Infectives Insight Series

AMR and Decision Resources' Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with Decision Resources' disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the reasons behind physicians' product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

About AMR

AMR (www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:
    Gisselle Morales
    Decision Resources
    781-296-2691
    gmorales@dresources.com

    Elizabeth Marshall
    Decision Resources, Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Decision Resources; Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
2. LMS integrated obstetrics solution achieves general availability
3. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
4. PA Breast Cancer Coalition Announces Special Press Availability for PA Breast Cancer Coalition Annual Conference
5. Pelosi to Hold Press Availability with SCHIP Family Tomorrow Morning
6. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
7. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
8. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
9. Visage Imaging Expands Availability of Its Advanced Visualization Offering
10. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
11. Dblur Announces the Availability of a Software Lens(TM) Enabled Chip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... HealthPostures, the ... sending an expert sit stand solutions representative to the Minneapolis Home and Garden Show ... for the event that is garnering national attention is the Minneapolis Convention Center. ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... enough to overwork even the sharpest brain. , Power On, a mental performance ... without over clocking the brain. Each capsule contains Cognizin® Citicoline, a branded form ...
(Date:2/22/2017)... MD (PRWEB) , ... February 22, 2017 , ... ... Direct secure messaging services to the largest network of hospitals, health information ... the National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module ...
(Date:2/22/2017)... (PRWEB) , ... February 22, ... ... Adjustment solution leverages advanced data analytics to accurately understand each Medicare Advantage ... reimbursement for a given population. This new solution helps transform the HCC ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Strategies - 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and ... Menopause market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... Feb. 23, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... it will release fourth quarter and yearly financial ... 2017. AcelRx management will host an investment-community conference ... Pacific Time) on March 2 nd 2017 ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Global Endoscopy Market is poised to grow ... reach approximately $47.6 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
Breaking Medicine Technology: